Neurodegenerative diseases

The case of the sticky protein

Proteins are like a body’s in-house Lego set. These large, complex molecules are made up of building blocks called amino acids. Most of the time, proteins fold correctly, but sometimes they can misfold. This misfolding causes the proteins to get sticky, and that can promote clumping, or aggregation, which is the hallmark of several neurodegenerative diseases such as ALS, Alzheimer’s and Parkinson’s.

Ashutosh Tiwari and his doctoral student Nethaniah Dorh work on misfolded...
Ashutosh Tiwari and his doctoral student Nethaniah Dorh work on misfolded proteins. They collaborated with synthetic chemists and physicists to better understand a BODIPY-based probe to test protein stickiness, a precursor to some neurodegenerative diseases.
Source: Michigan Tech/Sarah Bird

The protein’s stickiness is a result of surface hydrophobic interactions that are important for many biological functions. The problem is that researchers don’t have good tools to measure this stickiness with high sensitivity.

Now, an interdisciplinary team at Michigan Technological University has assembled new tools to solve the case of the sticky protein. Their work on improving hydrophobicity detection using BODIPY-based probes will be published in Scientific Reports.

Using fluorescent probes, the team measured hydrophobicity in three proteins: Bovine Serum Albumin (BSA), apomyoglobin and myoglobin. Compared to a commonly used commercial sensor (ANS), these new BODIPY-based hydrophobic sensors showed much stronger signal strengths, with up to a 60-fold increase in BSA.

“This is like going from having one 40-watt light bulb and then having 60 of them in the same room, just imagine the difference in illumination,” says Ashutosh Tiwari, an associate professor of chemistry at Michigan Tech and the corresponding author for the study.


Source: Michigan Technological University

07.01.2016

More on the subject:
Read all latest stories

Related articles

Photo

Parkinson’s diseases

Better biosensor technology created for stem cells

Researchers have created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders.

Photo

Macular degeneration as a biomarker

Eye scan shows diseases at an early stage

More and more people aged 50 and over are suffering from age-related vision disorders. According to the World Health Organization, in four out of five cases they could be avoided if they were…

Photo

CMT, Alzheimer's, Parkinson's

Study links key protein to Charcot-Marie-Tooth and other nerve diseases

A new study provides critical insight into a little-known, yet relatively common, inherited neurological condition called Charcot-Marie-Tooth disease (CMT). The findings point to a pathway to…